Patents by Inventor Min Kyoo Shin

Min Kyoo Shin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF SHORT-CHAIN DEHYDROGENASE ACTIVITY FOR TREATING NEURODEGENERATION
    Publication number: 20230310390
    Abstract: A method of treating neurodegeneration and/or neurodegenerative condition, disease, or disorder caused by and/or associated with elevated or aberrant 15-PGDH activity in a subject in need thereof includes administering to the subject a therapeutically effective amount of a 15-PGDH inhibitor.
    Type: Application
    Filed: August 9, 2021
    Publication date: October 5, 2023
    Inventors: Sanford Markowitz, Andrew Pieper, Hongyun Li, Edwin Vazquez Rosa, Min-Kyoo Shin, Yeojung Koh, Joseph Ready
  • METHODS AND COMPOSITIONS FOR REPAIRING THE BLOOD-BRAIN BARRIER AND OTHER ENDOTHELIUM
    Publication number: 20230112662
    Abstract: Provided herein, in one aspect, is a method of treating a disease or condition associated with insufficient levels of claudin-5, comprising providing a subject having insufficient levels of claudin-5, and administering an effective amount of a P7C3 compound to the subject.
    Type: Application
    Filed: October 8, 2021
    Publication date: April 13, 2023
    Inventors: Andrew A. Pieper, Min-Kyoo Shin, Edwin Vázquez-Rosa, Kalyani Chaubey, Matasha Dhar
  • Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
    Patent number: 8557960
    Abstract: Disclosed are peptides for augmenting the expression of BDNF (brain-derived neurotrophic factor) and a pharmaceutical composition for the prevention and treatment of Alzheimer's disease or Parkinson's disease, comprising the same. The peptides can induce the expression of BDNF in dopamine-reactive human cells, pass easily through the blood-brain barrier thanks to their low molecular weights and are almost free of cytotoxicity. Thus, they are useful in the prevention and treatment of neuropathies such as Alzheimer's disease or Parkinson's disease.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: October 15, 2013
    Assignee: Sungkyunkwan University
    Inventors: Kil Lyong Kim, Hong Gi Kim, Woo Ram Jung, Dong Ik Park, Min Kyoo Shin
  • NOVEL PEPTIDE FOR AUGMENTING AND EXPRESSION OF BDNF AND PHARMACEUTICAL COMPOSITION FOR PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES INCLUDING ALZHEIMER'S DISEASE OR PARKINSON'S DISEASE, COMPRISING THE SAME
    Publication number: 20120208747
    Abstract: Disclosed are peptides for augmenting the expression of BDNF (brain-derived neurotrophic factor) and a pharmaceutical composition for the prevention and treatment of Alzheimer's disease or Parkinson's disease, comprising the same. The peptides can induce the expression of BDNF in dopamine-reactive human cells, pass easily through the blood-brain barrier thanks to their low molecular weights and are almost free of cytotoxicity. Thus, they are useful in the prevention and treatment of neuropathies such as Alzheimer's disease or Parkinson's disease.
    Type: Application
    Filed: December 31, 2009
    Publication date: August 16, 2012
    Applicant: SUNGYUNKWAN UNIVERSITY FOUNDATION FOR CORPORATE COLLABORATION
    Inventors: Kil Lyong Kim, Hong Gi Kim, Woo Ram Jung, Dong Ik Park, Min Kyoo Shin